Lv11
58 积分 2023-05-17 加入
N-Nitrosamine Drug Substance Related Impurities (NDSRIs) – A proposal for the addition of subcategories to Carcinogenic Potency Categorisation Approach categories 1 and 2 for NDSRIs with a molecular weight > 200 Da
28天前
已完结
Approaches and Considerations for the Investigation and Synthesis of N-Nitrosamine Drug Substance-Related Impurities (NDSRIs)
1个月前
已完结
Neuroanatomy of Pathological Laughing and Crying: A Report of the American Neuropsychiatric Association Committee on Research
1个月前
已完结
PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
1个月前
已完结
Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect
1个月前
已完结
Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA®) for Pseudobulbar Affect
1个月前
已完结
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML
1个月前
已完结
Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML
1个月前
已关闭
“Inactive” Ingredients in Pharmaceutical Products: Update (Subject Review)
1个月前
已完结
Paediatric and geriatric drug delivery
1个月前
已关闭
皖公网安备34019202002308
